The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Japanese Clinical Practice Guideline for Diabetes 2016
Open accessAbstract
statements were developed separately as general questions and clinical questions based on published clinical evidence as well as expert consensus.This guideline offers key recommendations for clinical practice that are supported by scientific evidence from published studies.Studies of interest were obtained by a systematic search of the English and Japanese literature.The electronic databases used for literature search included at least MED-LINE and the Japanese ICHUSHI database (http://www.jamas. or.jp/).The search strategies used were developed by each author.The studies of interest were critically appraised by the authors to determine their relevance to the statements of the guideline and whether they were worth citing.Each study was assigned a level of evidence using the approach described in Table 1.Each statement for the CQs was assigned a grade of recommendation based on the total body of evidence as well as the risk-benefit balance, value, patient preferences, cost, and resources.Statements were graded as A (strongly recommended) or B (recommended), followed by the agreement rate among authors.Grade A or B by consensus reflects a recommendation based solely on the consensus of professionals and indicates that the recommendation was adopted with a ≥70% agreement rate among the authors.A summary table, including an identifier, the research design, the level of evidence and population, methods, and results of the cited articles was attached at the end of each chapter in the original Japanese version (The Japan Diabetes Society: Japanese Clinical Practice Guideline for diabetes 2016.Tokyo: Nankodo, 2016.).Scientific reports supporting a statement were cited as 'References' and additional guidelines or review articles were listed as 'Additional reference materials'.The guideline will be reviewed every 3 years, as there will be considerable advances in clinical research and practice that will require a re-evaluation of the scientific evidence as it becomes available.All potential conflicts of interest were disclosed by authors. GUIDELINE FOR THE DIAGNOSIS OF DIABETES MELLITUSQ1-1 How is diabetes diagnosed?(Figure 1)• The diagnosis of diabetes mellitus should be as comprehensive as possible.It is confirmed by the presence of chronic hyperglycemia, and by the presence of other factors, such as associated symptoms, clinical laboratory findings, a family history of diabetes, and the patient's body weight history 1-5 .For the diagnosis of diabetes, either of the following approaches is to be followed: ① Two assessments of the diabetic type in each patient (one blood glucose test is mandatory).② One assessment of the diabetic type (with mandatory blood glucose testing) along with the presence of chronic hyperglycemic symptoms*.(*typical symptoms of chronic hyperglycemia (e.g., dry mouth, polyposia, polyuria, body weight loss, or diabetic retinopathy).③ Evidence of a prior diagnosis of 'diabetes'.Q1-2 How is hyperglycemia assessed?(Figure 2)• Patients are to be classified into the normal type, borderline type, or diabetic type, based on the combination of fasting and 2-h post-75 g oral glucose tolerance test (OGTT) glucose values.• Patients whose fasting glucose values are 100-109 mg/dL (5.6-6.1 mmol/L) are classified into the 'high normal' category as part of the normal type 6 .• The OGTT is to be proactively considered in high-risk individuals (i.e., those who are suspected to have diabetes or the borderline type, those whose fasting glucose values are shown to be 'high-normal', those with HbA1c values of ≥5.6%, those with obesity or dyslipidemia, and those with a strong family history of diabetes 5 ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501352 · Cited by 2,577
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901
Collaborative care for patients with depression and chronic illnesses
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003955 · Cited by 1,697
Quantity and Quality of Sleep and Incidence of Type 2 Diabetes
Cappuccio, F. P., D'Elia, L., Strazzullo, P., & Miller, M. A. (2010) · Diabetes Care · doi:10.2337/dc09-1124 · Cited by 1,670
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Umpierre, D. (2011) · JAMA · doi:10.1001/jama.2011.576 · Cited by 1,358
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Active Smoking and the Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D., & Cornuz, J. (2007) · JAMA · doi:10.1001/jama.298.22.2654 · Cited by 1,268
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Long-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Physical Activity of Moderate Intensity and Risk of Type 2 Diabetes
Jeon, C. Y., Lokken, R. P., Hu, F. B., & van Dam, R. M. (2007) · Diabetes Care · doi:10.2337/dc06-1842 · Cited by 758
Alcohol as a Risk Factor for Type 2 Diabetes
Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009) · Diabetes Care · doi:10.2337/dc09-0227 · Cited by 703
Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684
Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes
Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J., Bouter, L. M., & Heine, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.719 · Cited by 671
Launer, L. J., Miller, M. E., Williamson, J. D., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M., Horowitz, K. R., Ding, J., Marcovina, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70188-0 · Cited by 574
(DPS), F. T. F. D. P. S., Lindström, J., Peltonen, M., Eriksson, J. G., Ilanne-Parikka, P., Aunola, S., Keinänen-Kiukaanniemi, S., Uusitupa, M., & Tuomilehto, J. (2013) · Diabetologia · doi:10.1007/s00125-012-2752-5 · Cited by 551
Fiber and Magnesium Intake and Incidence of Type 2 Diabetes: A Prospective Study and Meta-analysis
Schulze, M. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.956 · Cited by 537
Shift work and diabetes mellitus: a meta-analysis of observational studies
Gan, Y., Yang, C., Tong, X., Sun, H., Cong, Y., Yin, X., Li, L., Cao, S., Dong, X., Gong, Y., et al. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102150 · Cited by 526
Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
(1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.874 · Cited by 509
The evidence for the effectiveness of medical nutrition therapy in diabetes management
Pastors, J. G., Warshaw, H., Daly, A., Franz, M., & Kulkarni, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.608 · Cited by 434
Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., & Heikkilä, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00002 · Cited by 433
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4127 · Cited by 412
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Individual patient education for people with type 2 diabetes mellitus
Duke, S.-A. S., Colagiuri, S., & Colagiuri, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005268.pub2 · Cited by 361
Winkley, K., Landau, S., Eisler, I., & Ismail, K. (2006) · BMJ · doi:10.1136/bmj.38874.652569.55 · Cited by 359
Changing Physical Activity Behavior in Type 2 Diabetes
Avery, L., Flynn, D., van Wersch, A., Sniehotta, F. F., & Trenell, M. I. (2012) · Diabetes Care · doi:10.2337/dc11-2452 · Cited by 340
Not Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
Vilsbøll, T., Rosenstock, J., Yki‐Järvinen, H., Cefalu, W. T., Chen, Y., Luo, E., Musser, B., Andryuk, P. J., Ling, Y., Kaufman, K. D., et al. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01173.x · Cited by 305
Kawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., & Kaku, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60222-1 · Cited by 303
Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A Systematic Review
Selvin, E., Bolen, S., Yeh, H.-C., Wiley, C., Wilson, L. M., Marinopoulos, S. S., Feldman, L., Vassy, J., Wilson, R., Bass, E. B., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2070 · Cited by 300
Saito, T. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.275 · Cited by 277
Diabetic Retinopathy and the Risk of Coronary Heart Disease
Cheung, N., Wang, J. J., Klein, R., Couper, D. J., Sharrett, A. R., & Wong, T. Y. (2007) · Diabetes Care · doi:10.2337/dc07-0264 · Cited by 267
Schwingshackl, L., Missbach, B., Dias, S., König, J., & Hoffmann, G. (2014) · Diabetologia · doi:10.1007/s00125-014-3303-z · Cited by 264
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Livingstone, S. J., Charlton-Menys, V., DeMicco, D. A., & Fuller, J. H. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.03.022 · Cited by 255
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group (2007) · Diabetes Care · doi:10.2337/dc06-1998 · Cited by 230
Self-citationWeight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221
Tshiananga, J. K. T., Kocher, S., Weber, C., Erny-Albrecht, K., Berndt, K., & Neeser, K. (2012) · The Diabetes Educator · doi:10.1177/0145721711423978 · Cited by 209
Risk Factors for Falls in Older Disabled Women With Diabetes: The Women's Health and Aging Study
Volpato, S., Leveille, S. G., Blaum, C., Fried, L. P., & Guralnik, J. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1539 · Cited by 203
Sone, H., Tanaka, S., Tanaka, S., Iimuro, S., Oida, K., Yamasaki, Y., Oikawa, S., Ishibashi, S., Katayama, S., Ohashi, Y., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0622 · Cited by 201
The diagnosis and management of monogenic diabetes in children and adolescents
Rubio-Cabezas, O., Hattersley, A. T., Njølstad, P. R., Mlynarski, W., Ellard, S., White, N., Chi, D. V., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12192 · Cited by 196
Griffin, M. E., Coffey, M., Johnson, H., Scanlon, P., Foley, M., Stronge, J., O’Meara, N. M., & Firth, R. G. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00214.x · Cited by 185
3. Foundations of Care and Comprehensive Medical Evaluation
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s006 · Cited by 159
Falavigna, M., Schmidt, M. I., Trujillo, J., Alves, L. F., Wendland, E. R., Torloni, M. R., Colagiuri, S., & Duncan, B. B. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.002 · Cited by 152
KATO, M., NODA, M., INOUE, M., KADOWAKI, T., & TSUGANE, S. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-003 · Cited by 120
Self-citationMonami, M., Dicembrini, I., Nardini, C., Fiordelli, I., & Mannucci, E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.010 · Cited by 106
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region
(2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280dce59e · Cited by 94
Research works printed but not linked: 232
- Kosaka K, 1982, Report of committee on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 25, 859
- World Health Organization, 1999, Report of a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus
- Kuzuya T, 1999, Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 42, 385
- 10.1007/s13340-010-0006-7 · DOI · Paper page
- Kadowaki T, 2008, Report of the Japan Diabetes Society's Committee on the diagnostic criteria for diabetes mellitus and glucose metabolism disorder―a new category of fasting plasma glucose values: “high‐normal”, J Jpn Diabetes Soc, 51, 281
- 10.1007/s13340-013-0122-2 · DOI · Paper page
- 10.1007/s13340-015-0210-6 · DOI
- 10.1111/jdi.12024 · DOI · Paper page
- 10.2169/naika.102.1829 · DOI
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Nakagawa Y, 2014, Impact of the duration of diabetes and frequency of counseling on the effectiveness of dietitian‐led medical nutrition therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 57, 813
- 10.1161/CIRCULATIONAHA.109.192521 · DOI · Paper page
- 10.1007/s00125-003-1160-2 · DOI · Paper page
- 10.1016/j.puhe.2007.02.014 · DOI · Paper page
- 10.1007/BF03262312 · DOI · Paper page
- 10.1371/journal.pone.0058861 · DOI · Paper page
- 10.2337/dc14-1140 · DOI · Paper page
- 10.1136/bmj.310.6972.83 · DOI · Paper page
- 10.1111/j.1600-051X.1988.tb01003.x · DOI · Paper page
- Bennett WL, 2011, AHRQ Comparative Effectiveness Reviews. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update
- Kaku K, 2006, Melbin observational research (MORE) study of metformin therapy in patients with type 2 diabetes mellitus, J Jpn Diabetes Soc, 49, 325
- 10.1001/archinte.168.8.820 · DOI · Paper page
- 10.1503/cmaj.080486 · DOI · Paper page
- 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
- 10.1007/s00125-012-2668-0 · DOI
- 10.1001/jama.299.13.1561 · DOI · Paper page
- 10.1007/s13340-011-0022-2 · DOI
- 10.1111/dom.12235 · DOI
- 10.1111/j.1463-1326.2007.00744.x · DOI · Paper page
- Iwakura T, 2010, A case of severe hypoglycemia induced by sitagliptin added to ongoing glimepiride therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 53, 505
- 10.1007/s13340-013-0109-z · DOI
- 10.1111/dom.12176 · DOI
- 10.1111/j.1463-1326.2009.01194.x · DOI
- 10.1111/j.1463-1326.2012.01618.x · DOI · Paper page
- 10.1111/dom.12244 · DOI · Paper page
- 10.7326/0003-4819-159-4-201308200-00007 · DOI · Paper page
- 10.1111/dom.12189 · DOI · Paper page
- 10.1046/j.1464-5491.2001.00582.x · DOI
- 10.2337/diacare.22.1.119 · DOI · Paper page
- 10.1046/j.1463-1326.2001.00141.x · DOI
- 10.1016/S0149-2918(00)83039-8 · DOI · Paper page
- 10.1111/j.1463-1326.2010.01326.x · DOI · Paper page
- 10.1185/03007990802711024 · DOI
- 10.1111/j.1464-5491.2009.02816.x · DOI
- 10.1111/dom.12229 · DOI
- 10.1111/ijcp.12322 · DOI · Paper page
- Takahashi Y, 1998, Clinical features of eighty‐six diabetic patients with post‐treatment painful neuropathy, J Jpn Diabetes Soc, 41, 165
- 10.7326/0003-4819-128-3-199802010-00001 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- Lawson ML, 1999, Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta‐analysis, Diabetes Care, 22, B35
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Shichiri M, 2000, Long‐term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21
- 10.1056/NEJMoa075392 · DOI · Paper page
- 10.1111/j.1463-1326.2008.00915.x · DOI
- 10.1016/S0168-8227(98)00003-5 · DOI
- 10.2337/diacare.25.2.330 · DOI · Paper page
- 10.1007/s00592-006-0231-5 · DOI
- 10.2337/diacare.24.10.1844 · DOI
- 10.2169/internalmedicine.46.0415 · DOI
- 10.7326/0003-4819-131-3-199908030-00004 · DOI · Paper page
- 10.1002/(SICI)1096-9136(1998120)15:12<997::AID-DIA716>3.0.CO;2-B · DOI
- 10.1016/S0149-2918(00)90005-5 · DOI
- Juntti‐Berggren L, 2000, Influence of acarbose on post‐prandial insulin requirements in patients with type 1 diabetes, Diabetes Nutr Metab, 13, 7
- Han A, 2004, Effect of combination therapy of premixtured 50 R and voglibose in patients with type 2 diabetes, J Jpn Diabetes Soc, 47, 137
- 10.1056/NEJM199803263381302 · DOI · Paper page
- 10.1016/j.clinthera.2005.05.005 · DOI
- 10.1016/j.diabres.2007.04.012 · DOI
- 10.2337/diacare.24.7.1226 · DOI · Paper page
- 10.1016/S0140-6736(14)61335-0 · DOI · Paper page
- 10.1016/j.pec.2009.09.033 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1016/S0002-9343(01)00742-2 · DOI · Paper page
- 10.2337/diacare.28.2.278 · DOI
- 10.1186/1471-244X-13-260 · DOI · Paper page
- 10.1001/archopht.1989.01070010243030 · DOI · Paper page
- 10.1001/archopht.1989.01070010250031 · DOI · Paper page
- 10.1016/S0140-6736(03)12267-2 · DOI · Paper page
- 10.1111/j.1464-5491.2009.02820.x · DOI
- 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- 10.1001/archopht.122.11.1631 · DOI · Paper page
- 10.1016/S0140-6736(07)61607-9 · DOI · Paper page
- 10.1016/S0161-6420(78)35693-1 · DOI · Paper page
- Evans JR, 2014, Laser photocoagulation for proliferative diabetic retinopathy, Cochrane Database Syst Rev, 11, CD011234
- 10.2337/diacare.18.5.631 · DOI · Paper page
- 10.1007/BF00137653 · doi:10.1007/bf00137653
- 10.2337/diacare.25.5.859 · DOI · Paper page
- 10.1161/01.STR.0000254547.91276.50 · DOI · Paper page
- 10.2337/dc12-1311 · DOI
- 10.1016/j.ophtha.2012.08.029 · DOI
- 10.1007/s00125-010-2025-0 · DOI
- 10.1053/j.ajkd.2008.12.034 · DOI · Paper page
- 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1001/archinternmed.2011.537 · DOI · Paper page
- 10.1136/bmj.317.7160.703 · DOI · Paper page
- 10.1111/j.1463-1326.2012.01566.x · doi:10.1111/j.1463-1326.2012.01566.x
- 10.1016/j.diabres.2004.02.015 · DOI
- 10.1016/S0140-6736(05)67814-2 · DOI · Paper page
- Suckling RJ, 2010, Altered dietary salt intake for preventing and treating diabetic kidney disease, Cochrane Database Syst Rev, CD006763
- 10.2337/diacare.24.1.111 · DOI
- 10.1046/j.1523-1755.2002.00421.x · DOI · Paper page
- 10.1007/s00125-009-1467-8 · DOI
- 10.1159/000190270 · DOI · Paper page
- 10.1681/ASN.2012070718 · DOI · Paper page
- 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
- Hotta N, 1996, Diabetic Neuropathy, 145
- 10.2337/diacare.28.4.956 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 10.1212/WNL.37.4.589 · DOI · Paper page
- 10.2337/dc07-2105 · DOI · Paper page
- 10.1111/j.1464-5491.2010.03152.x · DOI
- 10.1111/j.1526-4637.2007.00305.x · DOI
- 10.1111/j.2040-1124.2010.00073.x · DOI
- 10.2337/dc10-0456 · DOI
- Japanese Study Group on Diabetic Neuropathy, 2012, Simplified diagnostic criteria and clinical staging of diabetic polyneuropathy, Peripheral Nerve, 23, 109
- 10.1016/S1067-2516(07)60001-5 · DOI · Paper page
- 10.2337/dc07-1178 · DOI · Paper page
- 10.1016/0002-9610(89)90183-9 · DOI · Paper page
- 10.1136/bmj.321.7258.405 · DOI · Paper page
- Edmonds ME, 1986, Improved survival of the diabetic foot: the role of a specialized foot clinic, Q J Med, 60, 763
- 10.1016/j.jacc.2011.08.023 · DOI · Paper page
- 10.1093/cid/cis346 · DOI · Paper page
- 10.1002/dmrr.2299 · DOI
- 10.1007/s001250051459 · DOI · Paper page
- 10.1016/S1262-3636(07)70193-3 · DOI
- 10.1016/j.jdiacomp.2007.06.006 · DOI
- 10.2337/diacare.27.6.1286 · doi:10.2337/diacare.27.6.1286
- 10.1007/s00125-012-2673-3 · DOI · Paper page
- 10.2337/dc13-1545 · DOI
- 10.1136/bmj.321.7258.405 · DOI · Paper page
- 10.1136/bmj.321.7258.412 · DOI · Paper page
- 10.2165/11638240-000000000-00000 · DOI
- 10.1371/journal.pone.0111247 · DOI
- 10.1007/s11606-011-1757-y · DOI
- 10.1016/S0140-6736(09)60503-1 · DOI · Paper page
- Takahashi K, 2001, Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus, J Int Acad Periodontol, 3, 104
- 10.1177/0022034511431583 · DOI
- 10.1111/jdi.12026 · DOI
- 10.2337/dc08-0026 · DOI · Paper page
- 10.1902/jop.2013.1340013 · DOI · Paper page
- 10.1902/jop.2013.1340017 · DOI
- Matsuzawa Y, 2006, Guidelines for the management of obesity disease 2006, Obesity Research, 12, 1
- Saito Y, 2011, Diagnostic criteria for obesity disease 2011, Obesity Research, 17, 1
- 10.1093/pubmed/fdt061 · DOI
- 10.1007/s11695-013-1160-3 · DOI · Paper page
- 10.2169/naika.94.794 · DOI · Paper page
- 10.2337/dc16-S012 · DOI
- 10.1161/CIRCULATIONAHA.110.016337 · DOI · Paper page
- 10.1111/j.1751-7176.2012.00648.x · DOI
- 10.1001/jama.2010.884 · DOI · Paper page
- 10.1016/S0272-6386(99)70036-3 · DOI · Paper page
- 10.1016/j.diabres.2013.07.009 · DOI
- 10.1161/CIRCULATIONAHA.113.002529 · DOI · Paper page
- 10.1186/1475-2840-11-109 · DOI
- 10.2337/diacare.22.6.889 · DOI · Paper page
- Hartweg J, 2008, Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus, Cochrane Database Syst Rev, CD003205
- 10.1016/j.diabres.2012.10.004 · DOI · Paper page
- 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
- 10.1016/S0140-6736(05)67667-2 · DOI · Paper page
- 10.1093/qjmed/94.8.435 · DOI · Paper page
- 10.2337/diacare.24.10.1739 · DOI · Paper page
- 10.2337/diacare.18.5.631 · DOI · Paper page
- Sanaka M, 2006, The allowance for pregnancy of women with diabeticnephropathy, J Jpn Soc Diabetes Pregn, 6, 127
- 10.1016/S0140-6736(10)60751-9 · DOI · Paper page
- 10.1016/S0002-9378(94)70097-4 · DOI · Paper page
- Hiramatsu Y, 2015, The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society “An abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria”, J Jpn Diabetes Soc, 58, 801
- 2015, ISPAD Clinical Practice Consensus Guidelines for Pediatric and Adolescent Diabetes 2014
- 10.1111/pedi.12182 · DOI
- 10.1111/pedi.12186 · DOI · Paper page
- 10.1111/pedi.12174 · DOI
- 10.1111/pedi.12179 · DOI · Paper page
- Urakami T, 2012, Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan, Pediatr Endocrinol Rev, 1, 51
- 10.1297/cpe.14.65 · DOI
- 10.2337/dc07-1785 · DOI · Paper page
- 10.1111/pedi.12187 · DOI
- 10.1111/pedi.12191 · DOI · Paper page
- 10.2337/diab.43.8.960 · DOI · Paper page
- 10.1111/j.1532-5415.2012.04099.x · DOI · Paper page
- 10.1111/j.1463-1326.2012.01583.x · DOI · Paper page
- 10.1016/S0140-6736(97)12355-8 · DOI · Paper page
- 10.1056/NEJM199804093381506 · DOI · Paper page
- 10.1016/j.diabres.2011.09.012 · DOI
- 10.2337/dc06-9909 · DOI · Paper page
- 10.1056/NEJMra1309483 · DOI · Paper page
- 10.2337/dc13-3023 · DOI · Paper page
- 10.1001/jama.2014.15298 · DOI · Paper page
- 10.2337/dc16-S004 · DOI
- 10.1056/NEJM199912163412507 · DOI · Paper page
- 10.1136/thoraxjnl-2012-203109 · DOI
- Moberley SA, 2013, Vaccines for preventing pneumococcal infection in adults, Cochrane Database Syst Rev, CD000422
- 10.1111/pedi.12193 · DOI
- 10.1007/s00125-012-2712-0 · DOI
- Sasai H, 2008, [Development of a diabetes risk prediction sheet for specific health guidance], Nihon Koshu Eisei Zasshi, 55, 287
- 10.1111/j.1464-5491.2011.03376.x · DOI
- 10.1093/aje/kws172 · DOI · Paper page
- 10.1097/EDE.0b013e31829f6c31 · DOI
- 10.1111/obr.12129 · DOI
200 of 232 shown
Cited by
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874
“, pancreatitis), and drug- or chemical-induced diabetes (such as after organ transplantation or in the treatment of human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS)) [1,19].”
BackgroundIto, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06870520 · Cited by 234
Yamada, Y., Katagiri, H., Hamamoto, Y., Deenadayalan, S., Navarria, A., Nishijima, K., Seino, Y., Fukushima, Y., Hamamoto, Y., Hisatomi, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30075-9 · Cited by 228
Yabe, D., Nakamura, J., Kaneto, H., Deenadayalan, S., Navarria, A., Gislum, M., Inagaki, N., Arisaka, T., Asakura, T., Azuma, N., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30074-7 · Cited by 210
Self-citationGouda, M., Matsukawa, M., & Iijima, H. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s176749 · Cited by 46
Metadata
- Authors
- Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E.
- Venue
- Journal of Diabetes Investigation
- Publisher
- Wiley
- Published
- 2018-03-26
- Volume
- 9
- Issue
- 3
- Pages
- 657-697
- ISSN
- 2040-1116 (ISSN-L)
- 2040-1124
- OpenAlex
- W4211190017
- Cited by
- 181
- References
- 84
- FWCI
- 24.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-18)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.